Lorraine M. Fathers

Medicine · Health Sciences

10h-index2.1kcitations15works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(10), Immunotherapy and Immune Responses(9), Immune Response and Inflammation(3), Genital Health and Disease(3), Cancer Immunotherapy and Biomarkers(2)

Publications15 total

Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
2023Open Access
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Clinical Cancer Research·2016· 163 cited
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
Cancer Immunology Immunotherapy·2013· 68 citedOpen Access
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Journal of Translational Medicine·2013· 186 citedOpen Access
Immunogenicity of P53 Synthetic Long Peptide Vaccination With Interferon-alpha Results in Increased P53-specific Polyfunctional T-cell Frequencies
Data Archiving and Networked Services (DANS)·2012
Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
International Journal of Cancer·2012· 59 citedOpen Access
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Cancer Immunology Immunotherapy·2012· 92 citedOpen Access
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
Proceedings of the National Academy of Sciences·2010· 236 citedOpen Access
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
New England Journal of Medicine·2009· 1.1k citedOpen Access
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Clinical Cancer Research·2009· 177 cited
Dynamics of egg counts and circulating antigen levels in a recent <i>Schistosoma mansoni</i> focus in northern Senegal
Tropical Medicine & International Health·2001· 15 citedOpen Access
Day-to-day fluctuation of schistosome circulating antigen levels in serum and urine of humans infected with Schistosoma mansoni in Burundi.
American Journal of Tropical Medicine and Hygiene·1998· 42 cited

Frequent Co-authors

Marij J.P. Welters(13), Jaap Oostendorp(13), Sjoerd H. van der Burg(13), A. Rob P.M. Valentijn(12), Gemma G. Kenter(10), Cornelis J.M. Melief(9), Mariëtte I.E. van Poelgeest(7), Hans W. Nijman(7), Bart W.J. Hellebrekers(7), Margriet J. Löwik(6), Dorien M. A. Berends-van der Meer(6), Linda F. M. Stynenbosch(6), Edith M.G. van Esch(6), Nikki M. Loof(6), Marjolein J. Kagie(6), Gert Jan Fleuren(5), Renee Vermeij(5), Marc van Beurden(5), Henk W.R. Schreuder(5), Toos Daemen(5)